Subject Delta displayed advanced mutation levels in vitro development inconsistent with the goals of Project LAYHR, and was slated for destruction. Before this could occur, anomalies presented themselves; Subject Delta has been moved to GeNtech Laboratories B-Wing for further research.

Subject displays advanced keratinous mutations among other skeletal abnormalities. Subject displays moderate arthritic tendencies in the joints due to said anomalies. Subject displays low physical activity and apathetic engagement, but unusual and heightened brainwave functionality.